ArticleHormones (Athens, Greece)2026
Neuroimaging findings of the hypothalamus and pituitary gland in children with growth hormone deficiency: a 25-year single-center retrospective study.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGrowth hormone deficiency (GHD) is a cause of short stature in childhood. Central nervous system imaging, including hypothalamic-pituitary magnetic resonance imaging (MRI) is important for the diagnostic investigation of these patients. The aim of this descriptive study was to examine the MRI findings of the hypothalamus-pituitary area in children with GHD.
methodsMedical records and MRI findings of the hypothalamus and pituitary gland were retrospectively reviewed for all patients diagnosed with GHD and treated with recombinant human GH during the 25-year period 1999-2024.
resultsThe study included 194 patients (138 boys, mean age at diagnosis 10.34 (4) years). Normal imaging findings were observed in 121/194 patients (62.3%), while abnormal findings were noted in 73/194 (37.6%) patients. Isolated or combined congenital structural anomalies of the hypothalamus-pituitary region, congenital pituitary variants, and tumors were also observed. The most frequent congenital imaging pituitary variants were pituitary hypoplasia, a partially empty sella turcica, and an ectopic posterior pituitary. Regarding tumors, 4/194 (2.1%) patients were diagnosed with craniopharyngiomas and 3/194 (1.5%) participants were diagnosed with germinomas in the hypophysis-hypothalamus region. Brain medulloblastomas were found in 3/194 (1.5%) patients. The 93.2% of the study sample (181/194) was diagnosed with isolated GHD, while in 13 patients (6.7%) multiple pituitary hormone insufficiency was established.
conclusionsImaging of the hypothalamus and pituitary in children with GHD is essential and often reveals benign findings/variants in the region, which should be taken into account during long-term follow-up for possible deficiency of other hormones. Craniopharyngiomas remain the most common tumor causing GHD.
Indexed as
Identifiers
42635910What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.